TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25566749

Group type: EXPERIMENTAL
Intervention: Single rhTSH administration after two weeks of T3 therapy followed by one week of THW (Group I)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard stimulating protocol via rhTSH injections for two consecutive days (Group II)
Number of subjects: 106
Study: 24236673

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics (four most commonly prescribed)
Number of subjects: 0
Study: 20810459

Group type: EXPERIMENTAL
Intervention: Script-based training group (S)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional training group (C)
Number of subjects: 70
Study: 19814586

Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl ODT
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 17848873

Group type: EXPERIMENTAL
Intervention: Caffeine (oral and intravenous) for PDPH prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine (oral) for PDPH treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine (IV) for PDPH treatment (from quasirandomized and open-label trials)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine as an antinociceptive agent for PDPH
Number of subjects: 0
Study: 15762403

Group type: EXPERIMENTAL
Intervention: Inoculation intervention programs designed to reinforce prosocial attitudes and prevent verbal aggression.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 11428448

Group type: COMPARATOR
Intervention: Penrose drain (Group B)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Semirigid suction drain (Group C)
Number of subjects: 150

Group type: COMPARATOR
Intervention: No drain (Group A)
Number of subjects: 150
Study: 9752637

Group type: EXPERIMENTAL
Intervention: Brief Supportive Psychotherapy (BSP)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Short‐Term Dynamic Psychotherapy (STDP)
Number of subjects: 49
Study: 8090093

Group type: EXPERIMENTAL
Intervention: Injection at L2/3 over 15 sec
Number of subjects: 40

Group type: COMPARATOR
Intervention: Injection at L4/5 over 15 sec
Number of subjects: 40

Group type: COMPARATOR
Intervention: Injection at L2/3 over 30 sec
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: L2/3 15 sec group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: L2/3 15 sec and L4/5 30 sec groups
Number of subjects: 40
Study: 3407611

Group type: EXPERIMENTAL
Intervention: 200 micrograms selenium as sodium selenite
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 170 mg alpha‐tocopherol acetate
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 30042065

Group type: EXPERIMENTAL
Intervention: TP53, KRAS, BRAF, and GNAS mutations
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Total somatic mutation burden
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Microsatellite instability (MSI)
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Total mutation burden (combined analysis of QUASAR 2 and Australian sample sets)
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: KRAS and BRAF mutations
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Prognostic model incorporating mutation burden and driver mutations in KRAS, BRAF, and TP53
Number of subjects: 807
Study: 27299514

Group type: EXPERIMENTAL
Intervention: Active Bright Light Therapy (BLT) at 10,000 lux for 45 minutes daily for 2 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control Bright Light Therapy (BLT) at approx. 100 lux for 45 minutes daily for 2 weeks
Number of subjects: 27
Study: 26591394

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combined aspirin and dipyridamole
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 21
Study: 23034468

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 25 mg with candesartan 8 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (CTD) 12.5 mg with candesartan 8 mg
Number of subjects: 28
Study: 21842274

Group type: EXPERIMENTAL
Intervention: frovatriptan 2.5 mg
Number of subjects: 93

Group type: COMPARATOR
Intervention: rizatriptan 10 mg
Number of subjects: 93
Study: 19443078

Group type: EXPERIMENTAL
Intervention: Chlorhexidine/silver sulfadiazine-impregnated CVCs (group 1)
Number of subjects: 109
Study: 16784610

Group type: EXPERIMENTAL
Intervention: Selective neck dissection (SND)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Modified radical neck dissection (MRND)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Accessory spinal nerve reserved
Number of subjects: 66

Group type: COMPARATOR
Intervention: Accessory spinal nerve resected
Number of subjects: 66
Study: 15205218

Group type: EXPERIMENTAL
Intervention: D-dimer
Number of subjects: 1419

Group type: EXPERIMENTAL
Intervention: IL-6
Number of subjects: 1419

Group type: EXPERIMENTAL
Intervention: C-reactive protein
Number of subjects: 1419

Group type: COMPARATOR
Intervention: Factor VII
Number of subjects: 1419

Group type: COMPARATOR
Intervention: Factor XIIa
Number of subjects: 1419
Study: 11315238

Group type: EXPERIMENTAL
Intervention: Very-low-energy diet (VLED) for 3 months
Number of subjects: 85

Group type: COMPARATOR
Intervention: Randomized controlled walking intervention (target energy expenditure 4.2 or 8.4 MJ/week) for 9 months
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Follow-up period of 24 months
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Weight change throughout the study
Number of subjects: 85
Study: 9495423

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 45 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 30 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (oral placebo and i.m. midazolam and atropine)
Number of subjects: 36
Study: 7817530

Group type: EXPERIMENTAL
Intervention: Eiconol-enriched antiatherosclerotic diet
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control diet (not specified)
Number of subjects: 73
Study: 3289837

Group type: EXPERIMENTAL
Intervention: Immediate bronchoscopy (group 2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Chest physical therapy alone (group 1)
Number of subjects: 20
Study: 31009399

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (PCB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 40
Study: 28679238

Group type: EXPERIMENTAL
Intervention: Adaptive Categorical Listening Effort Scaling (adaptive procedure for controlling SNR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static procedure using fixed, predefined SNRs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adaptive procedure
Number of subjects: 0
Study: 26060295

Group type: EXPERIMENTAL
Intervention: Maraviroc (MVC) 150 mg once daily
Number of subjects: 262

Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate (TDF) 300 mg once daily
Number of subjects: 262
Study: 23849941

Group type: EXPERIMENTAL
Intervention: Comprehensive staging surgery
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Oophorectomy
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Tumor resection
Number of subjects: 105

Group type: COMPARATOR
Intervention: Comparison of pregnancy rates
Number of subjects: 105

Group type: COMPARATOR
Intervention: Comparison of recurrence rates
Number of subjects: 105

Group type: COMPARATOR
Intervention: Comparison of death rates
Number of subjects: 105

Group type: COMPARATOR
Intervention: Comparison of survival rates
Number of subjects: 105
Study: 21533330

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation for 30 min, 5 days a week for 3 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group receiving standard rehabilitation programme
Number of subjects: 46
Study: 20120789

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Folic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron-folic acid
Number of subjects: 0
Study: 16675499

Group type: EXPERIMENTAL
Intervention: Arm exercise (A) in upright position
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Leg exercise (L) in upright position
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Combined arm and leg exercise (A + L) in upright position
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Arm exercise (A) in supine position
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Combined arm and leg exercise (A + L) in supine position
Number of subjects: 11
Study: 15517300

Group type: EXPERIMENTAL
Intervention: Infliximab, 5 mg/kg at week 0/2/6, followed by 5 mg/kg every 6 weeks in an open study.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 11181366

Group type: EXPERIMENTAL
Intervention: Ethionamide (ETA) administered with orange juice
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ethionamide (ETA) administered with food
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ethionamide (ETA) administered with antacids
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ethionamide (ETA) administered on an empty stomach (reference)
Number of subjects: 12
Study: 9310718

Group type: EXPERIMENTAL
Intervention: Fluorescence technique for teaching application of protective creams
Number of subjects: 50

Group type: COMPARATOR
Intervention: Instructive videotape for teaching application of protective creams
Number of subjects: 50
Study: 8257616

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering intervention through local hospitals or physicians' offices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not offered the intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering drug use at follow-up
Number of subjects: 0
Study: 3084754

Group type: EXPERIMENTAL
Intervention: Percutaneous central venous lines
Number of subjects: 53

Group type: COMPARATOR
Intervention: Surgical placement of catheters
Number of subjects: 53
Study: 29691791

Group type: EXPERIMENTAL
Intervention: Intrinsic religious orientation
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Extrinsic personal religious orientation
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Quest religious orientation
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Narcissistic Personality Disorder symptoms
Number of subjects: 618
Study: 29246552

Group type: EXPERIMENTAL
Intervention: del Nido cardioplegia
Number of subjects: 89

Group type: COMPARATOR
Intervention: whole blood cardioplegia
Number of subjects: 89
Study: 26024678

Group type: EXPERIMENTAL
Intervention: Vitamin D2 supplementation
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo vs No fracture group
Number of subjects: 39
Study: 24858566

Group type: COMPARATOR
Intervention: Live attenuated influenza vaccine (LAIV) administered intranasally at doses of 1×10(5), 1×10(6), or 1×10(7) TCID50
Number of subjects: 0

Group type: COMPARATOR
Intervention: Live attenuated influenza vaccine (LAIV) administered intranasally
Number of subjects: 0
Study: 21981973

Group type: EXPERIMENTAL
Intervention: Intensive statin therapy (IST) during hospitalization
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Intensive statin therapy (IST) continued after discharge
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Statin use at discharge
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Eligibility for IST
Number of subjects: 111
Study: 19682735

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation for 24 h
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation as rescue therapy
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 106
Study: 17403946

Group type: EXPERIMENTAL
Intervention: Thalidomide in combination with dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplant
Number of subjects: 0
Study: 16323383

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 30
Study: 11950491

Group type: EXPERIMENTAL
Intervention: MPA at dose of 2.5 mg daily (group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MPA at dose of 5 mg daily (group B)
Number of subjects: 30
Study: 9798809

Group type: EXPERIMENTAL
Intervention: Intravenous pantoprazole 40 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral pantoprazole 40 mg
Number of subjects: 20
Study: 7636093

Group type: EXPERIMENTAL
Intervention: Clean intermittent catheterization
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sterile intermittent catheterization
Number of subjects: 80
Study: 1996436

Group type: EXPERIMENTAL
Intervention: Iron dextran (Imferon; Fisons) - usual recommended dose
Number of subjects: 60

Group type: COMPARATOR
Intervention: Iron dextran (Imferon; Fisons) - two-thirds of the recommended dose
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral iron
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Iron dextran (Imferon; Fisons) - both doses
Number of subjects: 60
Study: 6394350

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg/day (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg/day (Group B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Slow release nifedipine 20 mg/day (Group C)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (Group D)
Number of subjects: 40
Study: 31269928

Group type: EXPERIMENTAL
Intervention: Group-based lifestyle modification program
Number of subjects: 573

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 573
Study: 29016461

Group type: EXPERIMENTAL
Intervention: Parental chronic pain (CP)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Parental reinforcing responses to adolescents' pain
Number of subjects: 154
Study: 26682971

Group type: EXPERIMENTAL
Intervention: Peer co-led educational intervention (four-hour group seminar)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Peer co-led educational intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 52
Study: 24846355

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 63

Group type: COMPARATOR
Intervention: Internal electrical shock
Number of subjects: 63
Study: 21293446

Group type: EXPERIMENTAL
Intervention: Nutrition (N; n = 39, 1×/week focused on decreasing sugar and increasing fiber intake)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nutrition + Strength Training (N+ST; n = 31, 2×/week)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (C; n = 30)
Number of subjects: 100
Study: 20977576

Group type: EXPERIMENTAL
Intervention: Exenatide twice-daily
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 18423812

Group type: EXPERIMENTAL
Intervention: Triple RAAS blockade (spironolactone 25 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Double RAAS blockade (cilazapril 5 mg, telmisartan 80 mg, hydrochlorothiazide 12.5 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Triple RAAS blockade
Number of subjects: 18
Study: 15731886

Group type: EXPERIMENTAL
Intervention: Self-report questionnaire measuring spider fear
Number of subjects: 240
Study: 12578431

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control (mood stabilizers only)
Number of subjects: 103
Study: 10080412

Group type: EXPERIMENTAL
Intervention: Carvedilol 25 to 50 mg twice daily
Number of subjects: 368

Group type: COMPARATOR
Intervention: Metoprolol 50 to 100 mg twice daily
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Carvedilol and Metoprolol (both low dose/high dose)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Carvedilol and Metoprolol
Number of subjects: 368
Study: 8006281

Group type: EXPERIMENTAL
Intervention: Heparin plus aspirin (150 mg once daily)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Transient myocardial ischemia presence
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Preadmission therapy with aspirin
Number of subjects: 285
Study: 2514151

Group type: EXPERIMENTAL
Intervention: Breathing with different gas mixtures or after hyperventilation
Number of subjects: 16
Study: 801570

Group type: EXPERIMENTAL
Intervention: aprotinin (Trasylol)
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 31195706

Group type: EXPERIMENTAL
Intervention: Starch‐ and sucrose‐reduced diet (SSRD) for 2 weeks
Number of subjects: 105

Group type: COMPARATOR
Intervention: Ordinary eating habits (Control)
Number of subjects: 105
Study: 28170396

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 152

Group type: COMPARATOR
Intervention: Conventional drugs
Number of subjects: 152
Study: 26173521

Group type: EXPERIMENTAL
Intervention: Intrinsic Stressors (IS)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Extrinsic Stressors (ES)
Number of subjects: 109
Study: 23767174

Group type: EXPERIMENTAL
Intervention: Propofol (100 mg/kg/min) with remifentanil (0.25 mg/kg/min)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Isoflurane (0.8% end‐tidal) with remifentanil (0.25 mg/kg/min)
Number of subjects: 100
Study: 21923601

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol sulfate 2.5 mg diluted in 3 ml of normal saline
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (3 ml of normal saline)
Number of subjects: 17
Study: 18326600

Group type: EXPERIMENTAL
Intervention: MCT oil (18-24 g/d)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 49
Study: 16507194

Group type: EXPERIMENTAL
Intervention: Combined anaesthesia group (1 mL kg‐1 of caudal-epidural bupivacaine 0.25%)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Balanced anaesthesia group (5 microg kg‐1 of intravenous fentanyl)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined anaesthesia group
Number of subjects: 26

Group type: COMPARATOR
Intervention: Balanced anaesthesia group
Number of subjects: 26
Study: 12865041

Group type: EXPERIMENTAL
Intervention: ARDFP+standard‐ART
Number of subjects: 1700

Group type: EXPERIMENTAL
Intervention: ARDFP+mega‐ART
Number of subjects: 1700

Group type: COMPARATOR
Intervention: no ARDFP+standard‐ART
Number of subjects: 1700

Group type: COMPARATOR
Intervention: no ARDFP+mega‐ART
Number of subjects: 1700
Study: 11007389

Group type: EXPERIMENTAL
Intervention: Textured silicone gel implants
Number of subjects: 53

Group type: COMPARATOR
Intervention: Smooth silicone gel implants
Number of subjects: 53
Study: 8686202

Group type: EXPERIMENTAL
Intervention: Low-protein diet (0.6-0.7 g/kg/day) and enalapril (2-10 mg/day)
Number of subjects: 38
Study: 8263317

Group type: EXPERIMENTAL
Intervention: Paroxetine 20-30 mg
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 2872174

Group type: EXPERIMENTAL
Intervention: Stress management
Number of subjects: 7

Group type: COMPARATOR
Intervention: Brief psychotherapy
Number of subjects: 7
Study: 30358715

Group type: EXPERIMENTAL
Intervention: 25‐mug 17beta‐estradiol vaginal tablets (Vagifem)
Number of subjects: 159

Group type: COMPARATOR
Intervention: 1.25‐mg conjugated equine estrogen vaginal cream (Premarin Vaginal Cream)
Number of subjects: 159
Study: 27501505

Group type: COMPARATOR
Intervention: S-1 alone
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: S-1 plus LNT
Number of subjects: 309
Study: 23588484

Group type: EXPERIMENTAL
Intervention: Prehabilitation (exercise intervention) 3 times per week for 8 weeks before TKA
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no prehabilitation)
Number of subjects: 31
Study: 22409735

Group type: EXPERIMENTAL
Intervention: Preventive home visit
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Four weekly multiprofessional senior group meetings with one follow-up home visit
Number of subjects: 459

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 459
Study: 20580740

Group type: EXPERIMENTAL
Intervention: Multi-faceted intervention program
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 33
Study: 18602429

Group type: EXPERIMENTAL
Intervention: High LC n-3 FA (>1300 mg/day)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Low LC n-3 FA (<260 mg/day)
Number of subjects: 233
Study: 15908621

Group type: EXPERIMENTAL
Intervention: Ever exclusively breast fed
Number of subjects: 2192

Group type: EXPERIMENTAL
Intervention: Breast fed for more than six months
Number of subjects: 2192

Group type: EXPERIMENTAL
Intervention: Exclusive breast feeding
Number of subjects: 2192
Study: 12460152

Group type: EXPERIMENTAL
Intervention: Dietary advice and individualized weight management advice for overweight patients (43 patients)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Usual care (42 patients)
Number of subjects: 84
Study: 10520385

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA) with morphine intravenously by a PCA Plus Micro Delivery Device for at least 48 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nurse-administered intravenous morphine followed by oral acetaminophen with or without codeine in 24 to 36 hours
Number of subjects: 0
Study: 7492860

Group type: EXPERIMENTAL
Intervention: Calcium intake (dietary plus supplemental)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 41
Study: 1935862

Group type: EXPERIMENTAL
Intervention: Sandocal containing 1 g of effervescent calcium
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Calsup containing 1 g of calcium as the carbonate
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Caltrate containing 1.2 g of calcium as the carbonate
Number of subjects: 35
Study: 7042111

Group type: EXPERIMENTAL
Intervention: Acebutolol 200 mg thrice daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acebutolol 400 mg thrice daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acebutolol (both dosages)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31078459

Group type: EXPERIMENTAL
Intervention: Digital breast tomosynthesis
Number of subjects: 28749

Group type: COMPARATOR
Intervention: Digital mammography
Number of subjects: 28749